Introduction
Hepatitis C virus (HCV) is a positive stranded RNA and enveloped virus. It belongs to the genus Hepacivirus of the family Flaviviridae. Fifteen percent of the individuals acquiring HCV infection clear it, whereas in remaining 85%, it may progress to chronic liver disease. The progression to chronicity depends on variable viral and host factors. The viral load and genotype have been prognostically implicated.
Human leucocyte antigens (HLAs) are encoded by major histocompatibility complex (MHC) located on short arm of chromosome no 6. HLA molecules bind and present peptide to T lymphocytes in cell-mediated immune response and play a key role in shaping the T-cell repertoire on it and are also associated with allograft rejections. HLA antigens are inherited in a codominant manner from parents Human leucocyte antigen Class I and II alleles associated with anti-hepatitis C virus-positive patients of North India Indian Journal of Medical Microbiology vol. 34, No. 3 vol. 34, No. 3 in the study. Out of these, six patients were positive for both anti-HCV antibodies and hepatitis B surface antigen (HBsAg). Healthy and unrelated, 154 individuals from the same ethnic background, who were negative for anti-HCV, anti-HIV antibodies and HBsAg were taken as controls.
Human leucocyte antigens typing
Low-resolution HLA typing for HLA-A, B, DR loci was performed by polymerase chain reaction sequence-specific primer (SSP) method (HLA-ABDR Invitrogen) using genomic DNA extracted from peripheral blood mononuclear cells by pure link genomic DNA extraction kit (Invitrogen). The primer set (AllSet+™ Gold SSP) contained 5' and 3' primers for grouping the HLA-A*01:01 to *80:01 alleles, 5' and 3' primers for grouping the B*07:02 to*83:01 alleles, 5' and 3' primers for grouping the DRB1*01:01 to DRB1*16:16. Amplified products were run on 2% agarose gel and gel image captured in Gel Documentation system and interpreted by Unimatch 6.0 CE-IVD software (Life Technologies Corporation).
Statistical analysis
The allele frequencies, odds ratio, Chi-square test and P values were calculated. P < 0.05 is considered to be statistically significant.
Results
When compared to the control population, it was observed that among the Class I alleles-(HLA-A, HLA-B), A*33 allele (odd ratio 1.85, P [Fisher exact] = 0.046) was increased significantly as compared to the control population. Similarly, A*02, A*31 allele frequency was decreased significantly in anti-HCV-positive patients as compared to control population.
In HLA-B locus, B*27 allele frequency was decreased significantly in anti-HCV-positive patients as compared to control population. However, the frequencies for HLA-B loci did not reach any statistical significance when compared with the control population.
Among the Class II alleles, HLA-DRB1*03 (odd ratio 1.89, P [Fisher's exact] = 0.005) and HLA-DRB1*10 (odd ratio 2.81, P [Fisher's exact] = 0.009) were statistically significantly higher in the patient population, and HLA-DRB1*15 was significantly decreased in the patient population as compared to the controls.
HLA distribution in anti-HCV-positive individuals and controls is tabulated in Table 1 .
Discussion
Genes located within the MHC play a major role in influencing the immune response against infectious agents. Optimal interactions between T-cell receptor, MHC Class Different allele and haplotype associations have been repeatedly reported with HCV, which varies with ethnicity and geographical location of the patients. We undertook this study to examine the frequencies of HLA Class I and Class II genotype profiles in anti-HCV infected patients of Northern India.
In the present study, HLA-A*33 was significantly increased as compared to control population. However, a study conducted from Western India indicates that the same allele was significantly decreased. [1] This was interesting as this allele showed a geographic variation with respect to HCV-positive patients.
HLA-DRB1*03 was found to be associated with HCV infection in our study group. Several other supportive findings have been demonstrated time and again in various study models. [2] [3] [4] Tripathy et al. [1] found that a significant increase in the allele DRB1*03 was present in the HCV-positive patients of Western India. Other alleles significantly increased in the HCV-infected patients as compared to control population in their study were HLA-A*03, A*26, A*32, A*66, B*08, B*15, B*55 and B*57, DRB1*12, DRB1*16 and DQB1*03. Furthermore, they found that the HLA Class II locus haplotype DRB1*11-DQB1*03 was significantly increased among HCV-infected individuals.
Interestingly, this HLA-DRB1*03, to be more specific, HLA-DRB1*03:01 is commonly associated with many autoimmune diseases such as rheumatoid arthritis [5] and has a positive association with systemic lupus erythematosus and autoimmune hepatitis. [6, 7] In our study, HLA typing was performed only at a low resolution; therefore, it was not possible to determine the prevalence at the allelic level. However, it still gives us an insights into the role of this HLA gene and its association with various autoimmune diseases.
Asti et al. [8] in their study found that the HLA-DRB1*10:01 was associated with the severity of the disease in HCV-infected individuals. This corroborated with our study wherein we observed a significant increase of HLA-DRB1*10 in HCV-infected individuals.
Wang et al. [9] showed that the HLA-A*02 shows opposing trends in different ethnic groups: Risk for Caucasians and protective for non-Caucasians. Although these associations were not statistically significant, interaction with race was evident. In our study as well, HLA-A*02 was significantly decreased as compared to the patient population as most of the patients included in our study were non-Caucasians.
No supportive evidence for association of HCV with A*31 was found. This needs to be studied further with larger study population from different ethnicities to prove it conclusively.
Conclusion
The findings of the present study were a significant increase among the allele frequencies of HLA-A*33, DRB1*03 and DRB1*10, and a significant decrease in frequency of A*02, A*31, DRB1*15 alleles among patients compared to controls.
HLA-A*33 was significantly increased as compared to control population and showed geographic variation in HCV-infected individuals of India.
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